ALEMS — European Medical Solutions SA Cashflow Statement
0.000.00%
- €19.97m
- €32.30m
- €49.92m
Annual cashflow statement for European Medical Solutions SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.241 | -5.58 | -5.02 | 0.547 | 1.84 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | — | 3.22 | 0.314 | 0.685 | 0.751 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.43 | 0.6 | -1.26 | -0.49 | 0.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.348 | 2.33 | -1.65 | 2.56 | 5.38 |
| Capital Expenditures | -1.92 | -2.21 | -2.72 | -3.57 | -2.88 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.578 | 1.22 | 1.25 | 0.68 | — |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.34 | -0.992 | -1.48 | -2.89 | -2.88 |
| Financing Cash Flow Items | -0.521 | 0.121 | 0 | -0.616 | -0.737 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2 | 0.471 | 3.48 | 0.718 | -2.19 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.01 | 1.8 | 0.362 | 0.383 | 0.309 |